[PDF][PDF] Multiple early factors anticipate post-acute COVID-19 sequelae
…, RA Cochran, ME Micikas, T Wrin, CJ Petropoulos… - Cell, 2022 - cell.com
Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However,
quantifiable risk factors for PASC and their biological associations are poorly resolved. We …
quantifiable risk factors for PASC and their biological associations are poorly resolved. We …
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
…, T Wrin, SJ Little, CJ Petropoulos - Proceedings of the …, 2003 - National Acad Sciences
A recombinant virus assay was used to characterize in detail neutralizing antibody responses
directed at circulating autologous HIV in plasma. Examining serial plasma specimens in a …
directed at circulating autologous HIV in plasma. Examining serial plasma specimens in a …
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
…, S Zolla-Pazner, H Katinger, CJ Petropoulos… - Journal of …, 2004 - Am Soc Microbiol
Broadly neutralizing monoclonal antibodies (MAbs) are potentially important tools in human
immunodeficiency virus type 1 (HIV-1) vaccine design. A few rare MAbs have been …
immunodeficiency virus type 1 (HIV-1) vaccine design. A few rare MAbs have been …
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
CJ Petropoulos, NT Parkin, KL Limoli… - Antimicrobial agents …, 2000 - Am Soc Microbiol
Although combination antiretroviral therapy has resulted in a considerable improvement in
the treatment of human immunodeficiency virus (HIV) type 1 (HIV-1) infection, the emergence …
the treatment of human immunodeficiency virus (HIV) type 1 (HIV-1) infection, the emergence …
[HTML][HTML] Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia
…, NS Hellmann, CJ Petropoulos… - … England Journal of …, 2001 - Mass Medical Soc
Background In many patients with human immunodeficiency virus (HIV) infection, therapy
with potent antiretroviral drugs does not result in complete suppression of HIV replication. The …
with potent antiretroviral drugs does not result in complete suppression of HIV replication. The …
Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors
SH Hughes, JJ Greenhouse, CJ Petropoulos… - Journal of …, 1987 - Am Soc Microbiol
We have previously described several helper independent vector constructions (S. Hughes
and E. Kosik, Virology 136:89-99, 1984; J. Sorge and SH Hughes, J. Mol. Appl. Genet. 1:547-…
and E. Kosik, Virology 136:89-99, 1984; J. Sorge and SH Hughes, J. Mol. Appl. Genet. 1:547-…
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy
…, Z Lu, D Cohen, T Wrin, CJ Petropoulos… - The Journal of …, 2008 - academic.oup.com
Background. Spontaneous control of human immunodeficiency virus (HIV) infection has
been documented in a minority of HIV-infected individuals. The mechanisms behind this …
been documented in a minority of HIV-infected individuals. The mechanisms behind this …
Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection
…, BC Yee, JW Winslow, CJ Petropoulos… - The Journal of …, 2021 - academic.oup.com
Background The biological processes associated with postacute sequelae of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) are unknown. Methods …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) are unknown. Methods …
Time trends in primary HIV-1 drug resistance among recently infected persons
…, M Warmerdam, L Liu, T Liegler, CJ Petropoulos… - Jama, 2002 - jamanetwork.com
ContextTransmission of multiclass drug-resistant human immunodeficiency virus type 1 (HIV-1)
may increase with wider use of antiretroviral therapy.ObjectiveTo determine trends in …
may increase with wider use of antiretroviral therapy.ObjectiveTo determine trends in …
[HTML][HTML] Chronic viral coinfections differentially affect the likelihood of developing long COVID
…, JW Winslow, CJ Petropoulos… - The Journal of …, 2023 - Am Soc Clin Investig
BACKGROUND The presence and reactivation of chronic viral infections, such as EBV, CMV,
and HIV, have been proposed as potential contributors to long COVID (LC), but studies in …
and HIV, have been proposed as potential contributors to long COVID (LC), but studies in …
